Luke Evnin's Reflection on his work at the SRF and their collaboration with Vie Ventures
Vie Ventures is collaborating with the Scleroderma Research Foundation because both organizations are oriented around accelerating progress from scientific insight to real-world impact, and because advancing scleroderma treatments increasingly requires coordinated efforts across research, clinical development, and translation. SRF brings deep disease-specific expertise, a strong research mandate, and a proven ability to convene top scientists and clinicians, while Vie Ventures contributes a venture-minded ecosystem that can help support commercialization pathways, early pilots, and strategic partnerships. The alignment is in pairing SRF’s mission-driven research leadership with a platform designed to help promising ideas move faster toward scalable, practical solutions that improve outcomes for people living with scleroderma.
The Scleroderma Research Foundation is a U.S.-based nonprofit dedicated to funding and advancing research to better understand, treat, and ultimately cure scleroderma, a rare and often life-threatening autoimmune disease. Focused on high-impact science and collaborative models, SRF supports basic, translational, and clinical research while bringing together leading experts across immunology, fibrosis, and related fields. Through targeted funding programs and coordinated research initiatives, the foundation works to shorten the timeline between discovery and meaningful therapeutic progress for patients.
